Stella Pharma Corporation
Stella Pharma Corporation (4888.T) Stock Overview
Explore Stella Pharma Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
14.3B
P/E Ratio
-101.38
EPS (TTM)
$-4.22
ROE
-0.05%
4888.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Stella Pharma Corporation (4888.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $841.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -101.38 and a market capitalization of 14.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.